No Data
No Data
Top Gap Ups and Downs on Monday: SMCI, ZM, GFI and More
What's Going On With Hims & Hers Health Stock Monday?
Hims & Hers Health Options Spot-On: On November 25th, 203.78K Contracts Were Traded, With 629.63K Open Interest
Dow, S&P, and Nasdaq Ended Higher to Start the Holiday Shortened Trading Week
Hims & Hers Health Trading 22% Higher, WIth Gains Attributed to FDA Nominee
After Trump's nomination of the FDA director, the supplier of "affordable weight loss drugs" Hims & hers surged more than 20%, reaching a historic high.
"Affordable weight loss pharmaceutical" supplier Hims & hers once rose over 20%, reaching $30.57, surpassing the previous intraday record high of $30.44 set on November 13. The reason is that institutions Hunterbrook Media, who benchmark against short sellers Citron, believe that Trump's nomination of Marty Makary as the director of the usa Food and Drug Administration (FDA) could benefit Hims & hers.
No Data
No Data
im_believer : My target is only 200 but let's goooooo!